Location: United States, Texas, Austin
Total raised: $55M
Investors 3
Funding Rounds 1
| Date | Series | Amount | Investors |
| 27.08.2020 | Series A | $55M | - |
Mentions in press and media 13
| Date | Title | Description | Source |
| 21.03.2022 | Climate tech companies in the spotlight as SEC votes on new ... | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 21.03.2022 | Triumvira Immunologics Closes Extension of Series A; Brings ... | Triumvira Immunologics, an Austin, TX-based clinical-stage company developing novel, targeted autolo... | finsmes.co... |
| 13.11.2021 | Triumvira Announces Data from Gastric Cancer Preclinical Stu... | Triumvira Immunologics (“Triumvira”), a clinical-stage company developing novel, targeted autologous... | marketscre... |
| 21.09.2021 | Triumvira Announces First Patient with HER2-overexpressing C... | Lonza and Triumvira Immunologics ("Triumvira") announced that the first patient has been d... | marketscre... |
| 26.04.2021 | Triumvira Appoints Teresa McRoberts as Chief Financial Offic... | Triumvira Immunologics (“Triumvira” or the “Company”), a privately held biopharmaceutical company de... | marketscre... |
| 30.08.2020 | Triumvira Immunologics raises $55M in Series A funding round... | The company’s pipeline consists of four preclinical assets, the most advanced of which are in studie... | medcitynew... |
| 27.08.2020 | Triumvira Immunologics Nabs $55M Series A | AUSTIN, TX, Triumvira Immunologics, a biopharmaceutical company developing a novel platform for en... | vcnewsdail... |
| 27.08.2020 | Triumvira snags $55M Series A to guide TAC technology ... | Triumvira Immunologics wants to bring its T-cell antigen coupler (TAC) technology to the c... | endpts.com... |
| 27.08.2020 | Triumvira Immunologics Raises USD $55M Series A Financing | Triumvira Immunologics Inc., an Austin, Texas-based biopharmaceutical company developing a novel pla... | finsmes.co... |
| 04.12.2018 | Triumvira Immunologics Demonstrates Prolonged TAC-T Cell Per... | New Preclinical Data Presented at Annual Meeting of American Society of Hematology AUSTIN, Texas &a... | venturebea... |
Show more